Switzerland: Go/ no-go decision launch of Rx product and OTC extension.
The local management of a tier-1 global pharma company wanted to understand the interest and sustainability of launching a Rx retail product in Switzerland, potentially an OTC line extension of the same product, and the impact on their own local product portfolio.
A tier 1 branded pharma products wanted to align skills & capabilities of MM / BM new hires, and optimize the yearly creation and update of marketing plans.
The local Commercial Head of a tier II global pharma company could not retain talent, and team turnover was >50% YoY. Operations were resented, as well as business results.
“...Thank you very much for your wonderful course, which is deeply impressive...”. Regional Training Manager, Asia
Find us on:
EU e-Privacy Directive
This website uses cookies to manage authentication, navigation, and other functions. By using our website, you agree that we can place these types of cookies on your device.